Neuromonics Tinnitus Treatment is a FDA-cleared, clinically proven treatment that distinctively targets the neurological processes underlying troublesome tinnitus perception. Treatment is provided by a specially trained audiologist and includes structured counseling and the use of auditory stimulation via audio recordings modified for each individual’s hearing loss, facilitating desensitization to the tinnitus signal. The implementation of the Neuromonics Tinnitus Treatment paradigm is a clinically proven treatment program with 90% of patients with troublesome tinnitus reporting a 45% reduction in troublesome tinnitus and a mean improvement of 65% (Davis, P.B. et al, 2007),
OTICON's NEW RISE and DELTA Tuesday, May 8, 2007 9:00 am-5:00 pm. Educational seminar. Demonstrations of Oticon Delta and the new Rise hearing aid with wireless bluetooth capability. TWO WEEK NO RISK TRIAL WITH OTICON DELTA OR RISE RESERVATIONS RECOMMENDED
January 25 and 26, 2007 9am-5pm call for reservation Phonak Hear the World Initiative
OTICON's NEW RISE and DELTA Tues., May 8, 2007 9:00 am-5:00 pm Educational seminar Demonstrations of Oticon Delta and the new Rise hearing aid with wireless bluetooth capability. TWO WEEK NO RISK TRIAL WITH OTICON DELTA OR RISE RESERVATIONS RECOMMENDED
RESOUND PULSE Tuesday December 12, 2006 9:00 am-5:00pm brunch catered by The Big Easy educational seminar demonstration of Resound Pulse RESERVATIONS RECOMMENDED
The PBS documentary "Spotlight on Hearing Loss", which is introduced by Internet co-founder Dr. Vinton Cerf, discusses the value of hearing as well as the hearing health care process and the making of hearing aids. Watch the video
Danish company Oticon recently introduced a new product called Delta that combines the technology hearing aids offer with a stylish accent. The device is designed not to cover the ear canal and is available in a variety of colors and patterns. Users can choose one to match their style while reaping the benefits of improved hearing. Read the article